UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act 1934
Date of
Report (date of earliest event reported): December 8, 2009
Advanced
Medical Institute Inc.
(Exact
name of registrant as specified in charter)
Nevada
(State or
other jurisdiction of incorporation)
|
000-29531
|
88-0409144
|
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
Level
4, Terrace Tower, 80 William Street
Sydney,
NSW
Australia
2000
(Address
of principal executive offices and zip code)
(61)
2-9640-5253
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On
December 8, 2009, Advanced Medical Institute Inc. (the “Company”) received
notification from Mr. Anatoly Fanshil and Mr. Spiro Baramalis that effective
immediately, they have resigned as directors of the Company. There were no
disagreements between either Mr. Fanshil and the Company or Mr. Baramalis and
the Company on any matter relating to the Company’s operations, policies or
practices, that resulted in their resignation.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| ADVANCED MEDICAL INSTITUTE INC. | |||
|
|
By:
|
/s/ Dilip Shrestha | |
|
Name: Dilip
Shrestha
Title: Chief
Financial Officer
|
|||
Dated:
December 10, 2009
3